Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $16.8K | $79.2K | $1.2K | $3.1K | $0 | $0 |
| Cost of revenue | $0 | $0 | $81.0K | $129.3K | $3.0K | $1.4K | $2.5M | $52.7K |
| Gross profit | $0 | $0 | −$64.3K | −$50.1K | −$1.8K | $1.7K | −$2.5M | −$52.7K |
| Gross margin | — | — | -383.1% | -63.2% | -151.0% | 53.9% | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $201.2K | $15.0K |
| Operating income | −$35.0K | −$13.5K | −$436.0K | −$627.0K | −$217.0K | −$258.4K | −$5.3M | −$1.4M |
| EBITDA | $0 | $0 | −$973.0K | −$168.0K | −$1.3M | $1.3M | −$38.3M | −$5.7M |
| Net income | −$35.0K | −$35.9K | −$976.0K | −$170.0K | −$2.6M | $1.0M | −$40.9M | −$6.0M |
| Net margin | — | — | -5819.6% | -214.5% | -218458.9% | 33766.2% | — | — |
| EPS (diluted) | -0.20 | -0.20 | -0.75 | -0.39 | -8.59 | 5.53 | -2.73 | -0.70 |
Annual figures · source: Financial Modeling Prep
INNOVATION1 BIOTECH IN
No one on the platform currently holds IVBT.
No tracked institution reports a position in IVBT as of their last filing.
No one on the platform has traded IVBT yet.
| $4359 |
| — |
| CALACalithera Biosciences, Inc. | $0.00 | +0.00% | $1949 | — |
| KLDOKaleido Biosciences, Inc. | $0.00 | +0.00% | $4262 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.